Type 1 Diabetes Trial, Recruiting NCT04039763 Sponsor: Imperial College London Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT04039763
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 25 years old
  • You have had diabetes treated with insulin for more than 12 months, either using daily injections or an insulin pump
  • At least one of the following applies to you: your long-term blood sugar level (HbA1c) is above a certain high threshold, OR you have been admitted to hospital with diabetic ketoacidosis (DKA) at least once in the last 12 months, OR you have been admitted to hospital with uncontrolled blood sugar levels at least once in the last 12 months (confirm with trial site if unsure which applies to you)
  • You have not previously used a real-time continuous glucose monitor (a sensor that constantly tracks your blood sugar levels), except possibly for short-term testing or check-up purposes
  • Having previously used a flash glucose monitor (a sensor you scan to check your blood sugar) is allowed

Who may not be able to join:

  • You have significant kidney disease where your kidneys are working at a reduced level (confirm with trial site)
  • You are currently pregnant or are planning to become pregnant
  • You are currently breastfeeding
  • You currently have cancer or are being investigated for a possible cancer diagnosis
  • You have a serious visual impairment that significantly affects your sight
  • You have difficulty with hand or finger movement that limits what you can do with your hands
  • There are other reasons that the lead researcher believes would prevent you from taking part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shivani Misra, Imperial College Healthcare NHS Trust

Phone: 02075946136

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 September 2020
Est. completion
30 June 2022

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Change in glycated haeomglobin (HbA1c)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov